Age, rather than hypertension duration, drives coronary endothelial degradation: an in situ post-mortem analysis

Oleh Samchuk1, Yevhen Panasyuk1, Vladyslav Bardash2

  • 1St. Panteleimon Hospital, First Lviv Medical Union, Lviv, Ukraine.

Insights

Chronological aging, not hypertension duration, significantly reduces coronary artery CD31 expression. Endothelial (CD31) and glycocalyx (CD138) markers show synchronized degradation in hypertensive patients.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Pathology

Background:

  • Arterial hypertension induces coronary vascular remodeling, but separating aging effects from hypertension's impact on the endothelium and glycocalyx is difficult.
  • Current research often relies on soluble markers, lacking direct tissue-level morphological evidence of degradation.

Purpose of the Study:

  • To investigate the independent effects of chronological age and hypertension duration on the coronary artery endothelium (CD31) and glycocalyx (CD138) in situ.
  • To provide direct morphological evidence of vascular remodeling in hypertensive patients.

Main Methods:

  • Observational post-mortem study of coronary artery fragments from 30 individuals (10 controls, 20 with essential hypertension).
  • Utilized immunohistochemistry and digital pathology for tissue analysis.
  • Applied multivariable linear regression modeling to the hypertensive cohort to isolate independent effects of age and hypertension duration.

Main Results:

  • Chronological age was significantly associated with reduced CD31 expression area in hypertensive patients (p=0.016).
  • Hypertension duration did not show an independent association with CD31 loss (p=0.076).
  • A significant positive correlation between CD31 and CD138 expression (R=0.50, p=0.025) indicated synchronized degradation of the endothelium and glycocalyx.

Conclusions:

  • Chronological age, not hypertension duration, is linked to decreased CD31 expression in coronary arteries of hypertensive individuals.
  • Synchronized degradation of the endothelium and glycocalyx was observed, suggesting a combined structural decline.
  • Emphasizes the need to differentiate physiological aging from pathological remodeling in vascular research.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...